FDA Inspection 1243567 — Aspirus - Wausau Hospital
The FDA completed an inspection of Aspirus - Wausau Hospital on May 14, 2024 in Wausau, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 14, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wausau, WI (United States)